Top Markets
Coin of the day
Theralase Technologies Inc. Theralase Technologies Inc.

Theralase Technologies Inc.

TLT
Clasificación en acciones #26501
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Precio por acción
$0.13944801
Capitalización bursátil
$41.23M
Cambio (1 día)
8.57%
Cambio (1 año)
-12.07%
País
CA
Comercio Theralase Technologies Inc. (TLT)

Categoría

Historial de desdoblamientos de acciones de Theralase Technologies Inc. (TLT)
La acción Theralase Technologies Inc. (símbolo: TLT) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 20, 2026.
Una acción TLT comprada antes de Aug 20, 2026 equivaldría hoy a 0 acciones TLT.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE